Consolidation in the global cellular space remains a focus for all the players.
A couple names are ripe because of the dislocation that has befallen their stock price as takeover talk ebbs and flows. We are targeting a trade in the biggest EM focused global player whose stock has been ravaged in the last 4 weeks.